Kirill Dmitriev, head of the Russian Direct Investment Fund, said that the Sputnik-V coronavirus vaccine could be launched in Russia in late October or early November.
On the air of the Russia-24 TV channel, Dmitriev stressed that the production of a vaccine against coronavirus will be aimed, first of all, at covering demand in Russia.
At the same time, according to the head of the RDIF, the Russian drug "Sputnik-V" may be approved in November in the Middle East.
Dmitriev also said that production of the Sputnik-V vaccine could begin at factories in China, India, Brazil, Korea and Turkey. According to the head of the RDIF, all Russian facilities will be directed to the production of vaccines for Russians, but if there is a shortage of the drug in Russia, it can be supplied from abroad.
Although, in general, production in other countries involves meeting the need for a vaccine in these countries themselves.
Let us recall that the Sputnik V vaccine, developed by the Gamaleya Research Center for Electrochemistry with the support of the Russian Direct Investment Fund, was registered on August 11, and on September 9 the post-registration phase of its trials began in Russia.
Earlier, the fight against coronavirus, including the use of the Russian Sputnik V vaccine, was discussed by Russian leader Vladimir Putin and Crown Prince of Abu Dhabi Mohammad bin Zayed Al Nahyan during a telephone conversation. It is known that clinical trials of the Russian Sputnik-V vaccine are already underway in the UAE.